Team Kapital sources new funding for science companies - in biotech, medtech, AI/Big Data, cleantech and agritech. Our USP is our ability to source equity investment funds from China for the UK's private or listed companies and we are well-known for our innovative work sourcing non-dilutive funding from China too. What is your China strategy?

Latest Articles

China, Britain and The Dangerous Oaf

China, Britain and The Dangerous Oaf

Where now for our promising life sciences and medtech relationship with China and the Chinese? The virus crisis seems to have polarised our...

Read More

Better Startups? Bring back the Grand Tour

Better Startups? Bring back the Grand Tour

The great country houses of Britain are full of beautiful art from other countries, but the UK’s great technology clusters have to paint t...

Read More

Live with passion

Live with passion

So I managed to fit in a single day's skiing last Sunday. Nothing very remarkable about that, you might think, until you learn that I haven...

Read More

Ready, Fire, Aim: pharma’s diagnosis-free growth strategy

Ready, Fire, Aim: pharma’s diagnosis-free growth strategy

So the global pharma and biotech industry still has a pipeline problem: cost per new drug is sky rocketing, volume of new approvals continue...

Read More


“Success means getting up just one more time than you fall down”–FortunePick Europe  #LessonLearned

“There is no idea that can't be improved upon: never settle, always evolve”–Michael Parks, Pick360  #LessonLearned

“Don't be afraid of failure but celebrate it and know what not to do next time”–Jeremy Rudolph, Palo Alto   #LessonLearned